Cargando…

CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer

It is desirable to have a biomarker which can facilitate low‐dose CT in diagnosis of early stage lung cancer. CTAPIII/CXCL7 is reported to be a potential biomarker for diagnosis of early lung cancer. In this study, we investigated the serum level of CTAPIII/CXCL7 in patients at different stage of lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Qiang, Li, Encheng, Liu, Yonge, Xie, Wenli, Huang, Chun, Song, Jiaqi, Zhang, Wei, Zheng, Yijie, Wang, Huiling, Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806116/
https://www.ncbi.nlm.nih.gov/pubmed/29356357
http://dx.doi.org/10.1002/cam4.1292